This study evaluated whether the phenotypic diversity of EpCAM-enriched, cytokeratin-positive objects (i.e., CTCs and tdEVs) in CS images of blood samples can identify operable CRC patients with poor prognosis. Here, EPCAM is linked to colorectal carcinoma.